In vivo epigenetic CRISPR screen identifies Asf1a as an immunotherapeutic target in Kras-mutant lung adenocarcinoma
Ontology highlight
ABSTRACT: In vivo epigenetic CRISPR screen identifies Asf1a as an immunotherapeutic target in Kras-mutant lung adenocarcinoma
PROVIDER: PRJNA576429 | ENA |
REPOSITORIES: ENA
ACCESS DATA